Literature DB >> 23435651

Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens.

Satoshi Yamasaki1, Akiko Miyagi-Maeshima, Yasuo Kakugawa, Yoshihiro Matsuno, Fusako Ohara-Waki, Shigeo Fuji, Yuriko Morita-Hoshi, Masakazu Mori, Sung-Won Kim, Shin-ichiro Mori, Takahiro Fukuda, Ryuji Tanosaki, Tadakazu Shimoda, Kensei Tobinai, Daizo Saito, Yoichi Takaue, Takanori Teshima, Yuji Heike.   

Abstract

Colonoscopic evaluation of mucosal tissues after allogeneic hematopoietic stem cell transplantation (HSCT) is very useful in evaluating pathogenesis and diagnosis of intestinal graft-versus-host disease (GVHD). However, information on the timing and sites of biopsies and the immunohistological evaluation of mucosal tissues for diagnosing intestinal GVHD, especially following reduced-intensity (RIC) regimens, remains very limited. A total of 33 patients with histologically proven GVHD after allogeneic HSCT with RIC (n = 23) and myeloablative conditioning (MAC, n = 10) regimens were enrolled in the present study. Colonoscopy was performed due to gastrointestinal symptoms, especially diarrhea and anorexia. Sites of biopsies with the worst histopathological grading were the terminal ileum in 67 % of patients. In the RIC group, the onset of diarrhea prior to colonoscopy examination was later (median: RIC, 57 vs. MAC, 27 days) and the number of patients who developed abdominal pain tended to be higher (RIC, 70 % vs. MAC, 30 %). A lower number of CD4+ cells and a higher ratio of Foxp3+ cells to CD4+ cells were detected in the involved lesions of intestinal GVHD following RIC. These differences in the RIC and MAC groups suggest that regimen-specific therapeutic strategies are required for diagnosing intestinal GVHD.

Entities:  

Mesh:

Year:  2013        PMID: 23435651     DOI: 10.1007/s12185-013-1297-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  17 in total

Review 1.  Pathophysiology of graft-versus-host disease.

Authors:  James L M Ferrara; Pavan Reddy
Journal:  Semin Hematol       Date:  2006-01       Impact factor: 3.851

2.  Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.

Authors:  José A Pérez-Simón; María Díez-Campelo; Rodrigo Martino; Salut Brunet; Alvaro Urbano; María D Caballero; Angel de León; David Valcárcel; Enric Carreras; María C del Cañizo; Jesús López-Fidalgo; Jordi Sierra; Jesús F San Miguel
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

Review 3.  Use of natural killer cells in hematopoetic stem cell transplantation.

Authors:  J R Passweg; M Stern; U Koehl; L Uharek; A Tichelli
Journal:  Bone Marrow Transplant       Date:  2005-04       Impact factor: 5.483

4.  Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

Authors:  Kathrin Rieger; Christoph Loddenkemper; Jochem Maul; Thomas Fietz; Daniel Wolff; Harald Terpe; Beate Steiner; Erika Berg; Stephan Miehlke; Martin Bornhäuser; Thomas Schneider; Martin Zeitz; Harald Stein; Eckhard Thiel; Rainer Duchmann; Lutz Uharek
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

5.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

Authors:  G R Hill; J M Crawford; K R Cooke; Y S Brinson; L Pan; J L Ferrara
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

Review 6.  Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.

Authors:  S Z Pavletic; S J Lee; G Socie; G Vogelsang
Journal:  Bone Marrow Transplant       Date:  2006-09-18       Impact factor: 5.483

7.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Authors:  Loredana Ruggeri; Marusca Capanni; Elena Urbani; Katia Perruccio; Warren D Shlomchik; Antonella Tosti; Sabrina Posati; Daniela Rogaia; Francesco Frassoni; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

8.  Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia.

Authors:  L Bergmann; K Fenchel; B Jahn; P S Mitrou; D Hoelzer
Journal:  Ann Oncol       Date:  1993-05       Impact factor: 32.976

9.  Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy.

Authors:  G E Sale; H M Shulman; G B McDonald; E D Thomas
Journal:  Am J Surg Pathol       Date:  1979-08       Impact factor: 6.394

10.  Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.

Authors:  D Zeng; D Lewis; S Dejbakhsh-Jones; F Lan; M García-Ojeda; R Sibley; S Strober
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.